Utah Admin. Code R414-60B-7 - Clinical and Cost-Related Factors

Current through Bulletin 2022-07, April 1, 2022

The P& T Committee shall base its determinations on the following factors as established by the DURB:

(1) If clinical and therapeutic considerations are substantially equal, then the P& T Committee shall recommend to DMHF that it consider only cost.
(2) In making its recommendations to DMHF, the P& T Committee may also consider whether the clinical, therapeutic effects, and medical necessity requirements justify the cost differential between drugs within a therapeutic class.

Notes

Utah Admin. Code R414-60B-7
Amended by Utah State Bulletin Number 2018-14, effective 6/27/2018

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.